Encore PFO Closure Device - The PerFOrm Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.
Also called NCT05537753
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 500 participants
- Registry
-
NCT05537753
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05537753. Randomized; no masking; primary purpose treatment. Start 2023-07-12 (actual); primary completion 2026-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Encore PFO Closure Device - The PerFOrm Trial
- Condition
- Patent Foramen Ovale
- Condition
- Cryptogenic Stroke
- Intervention (Device)
- Encore PFO closure device
- Intervention (Device)
- FDA-approved PFO closure device
- Lead sponsor
- Encore Medical Inc.
- Collaborator
- Bright Research Partners
- Collaborator
- Yale Cardiovascular Research Group
Record details
- Record id
cardio:ct-nct05537753- Content hash
54f9a15a5e60f55632e420360e8d701c3d87d46ff80a3c54040ac6f27e8f8d75